#redchip

Latest posts tagged with #redchip on Bluesky

Trending

#MJF Tribute #Javier Bardem #WBC #Marty Supreme #Andrade #Jessie Buckley #Academy Awards #MBJ #Autumn Durald Arkapaw #Wallace #MJF Tribute #Javier Bardem #WBC #Marty Supreme #Andrade #Jessie Buckley #Academy Awards #MBJ #Autumn Durald Arkapaw #Wallace

Posts tagged #redchip

Thiard News@F4F

@newsen.bsky.social

7 months ago

XTI Aerospace to Host Live Investor Webinar on TriFan 600 Aircraft Innovations Join XTI Aerospace for a live webinar on July 31, 2025, featuring insights on their innovative TriFan 600 VTOL aircraft and industry trends.

XTI Aerospace to Host Live Investor Webinar on TriFan 600 Aircraft Innovations #USA #Englewood #XTI_Aerospace #TriFan_600 #RedChip

0 0 0 0

Profit Trading USA

@profittradingusa.bsky.social

8 months ago

Brag House to Be Featured on RedChip Small Stocks, Big Money™ Show on Bloomberg TV - GlobeNewswire Brag House to Be Featured on RedChip Small Stocks, Big Money™ Show on Bloomberg TV GlobeNewswire

Click Subscribe #BragHouse #RedChip #SmallStocks #BigMoney #BloombergTV

0 0 0 0

abancommercials.com

@abancommericials.bsky.social

10 months ago

redchip companies: discovering tomorrow's blue chips today ad 2025 ✓ VIDEO RedChip Companies: Discovering Tomorrow's Blue Chips Today TV commercial 2025 • RedChip Companies: Discovering Tomorrow's Blue Chips Today RedCh...

RedChip Companies: Discovering Tomorrow's Blue Chips Today commercial
#RedChip #abancommercials #commercial Video RedChip Companies: Discovering Tomorrow's Blue Chips Today commercial, actor, actress, girl, cast, song
abancommercials.com/redchip/comp...

0 0 0 0

CyPath® Lung

@cypathlung.bsky.social

11 months ago

bioAffinity (Nasdaq: BIAF) CEO Maria Zannes Talks CyPath® Lung, Growth & AI Innovation bioAffinity Technologies (Nasdaq: BIAF) addresses the urgent need for noninvasive, accurate early-stage cancer diagnosis and broad-spectrum cancer treatments. Lung cancer is the leading cause of cancer-related deaths. The Company’s first product, CyPath® Lung, improves early-stage detection of lung cancer, leading to increased survival, fewer unnecessary invasive procedures, reduced patient anxiety, and lower medical costs. CyPath® Lung, a laboratory developed test (LTD), is patient-friendly and physician focused. Physicians order CyPath® Lung for their patients after lung cancer screening or other imaging reveals a suspicious finding. Patients collect their sample at home and ship overnight in a pre-paid envelope to the Company’s commercial laboratory, Precision Pathology Laboratory Services, where data is collected using flow cytometry. Proprietary automated data analysis, developed using artificial intelligence (AI), detects lung cancer by analyzing the lung microenvironment to identify cell populations that indicate malignancy. CyPath® Lung has shown high sensitivity (92%), high specificity (87%) and high accuracy (88%) in detecting early-stage lung cancer in patients with small pulmonary nodules less than 20 millimeters. Research and optimization of the Company’s platform technologies are conducted in its laboratories at Precision Pathology. bioAffinity is a client of RedChip. Visit www.redchip.com/stocks/BIAF to learn more.

bioAffinity CEO Maria Zannes will be interviewed on RedChip’s Small Stocks Big Money™ show on Bloomberg TV Saturday, March 29, at 7 p.m. ET. If you miss the interview, it can be viewed at bit.ly/4cdK2vW.
#BIAF #lungcancer #CyPathLung #Bloomberg #RedChip

0 0 0 0